GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer via β-catenin axis

References

• Adela, Ramu, and Sanjay K. Banerjee. 2015. “GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.” Journal of Diabetes Research 2015: 490842. https://doi.org/10.1155/2015/490842.
   PubMed Web of Science ®Google Scholar
• Alexa-Stratulat, Teodora, Milica Pešić, Ana Čipak Gašparović, Ioannis P. Trougakos, and Chiara Riganti. 2019. “What Sustains the Multidrug Resistance Phenotype beyond ABC Efflux Transporters? Looking beyond the Tip of the Iceberg.” Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 46 (September): 100643. https://doi.org/10.1016/j.drup.2019.100643.
   PubMedGoogle Scholar
• Bass, Adam J., Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, Roel G. Verhaak, So Young Kim, et al. 2009. “SOX2 Is an Amplified Lineage-Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas.” Nature Genetics 41 (11): 1238–1242. https://doi.org/10.1038/ng.465.
   PubMed Web of Science ®Google Scholar
• Boiani, Michele, and Hans R. Schöler. 2005. “Regulatory Networks in Embryo-Derived Pluripotent Stem Cells.” Nature Reviews. Molecular Cell Biology 6 (11): 872–884. https://doi.org/10.1038/nrm1744.
   PubMed Web of Science ®Google Scholar
• Bootcov, Michelle R., Asne R. Bauskin, Stella M. Valenzuela, Anthony G. Moore, Mohinder Bansal, Xiao Yan He, Hong Ping Zhang, et al. 1997. “MIC-1, a Novel Macrophage Inhibitory Cytokine, Is a Divergent Member of the TGF-β Superfamily.” Proceedings of the National Academy of Sciences 94 (21): 11514–11519. https://doi.org/10.1073/pnas.94.21.11514.
   PubMed Web of Science ®Google Scholar
• Brooks, Susan A., Tracey M. Carter, Eric P. Bennett, Henrik Clausen, and Ulla Mandel. 2007. “Immunolocalisation of Members of the Polypeptide N-Acetylgalactosaminyl Transferase (ppGalNAc-T) Family Is Consistent with Biologically Relevant Altered Cell Surface Glycosylation in Breast Cancer.” Acta Histochemica 109 (4): 273–284. https://doi.org/10.1016/j.acthis.2007.02.009.
   PubMed Web of Science ®Google Scholar
• Chaffer, Christine L., and Robert A. Weinberg. 2011. “A Perspective on Cancer Cell Metastasis.” Science 331 (6024): 1559–1564. https://doi.org/10.1126/science.1203543.
   PubMed Web of Science ®Google Scholar
• Cho, Yunhee, Hyeok Gu Kang, Seok-Jun Kim, Seul Lee, Sujin Jee, Sung Gwe Ahn, Min Jueng Kang, et al. 2018. “Post-Translational Modification of OCT4 in Breast Cancer Tumorigenesis.” Cell Death and Differentiation 25 (10): 1781–1795. https://doi.org/10.1038/s41418-018-0079-6.
   PubMed Web of Science ®Google Scholar
• Chugh, Seema, Vinayaga S. Gnanapragassam, Maneesh Jain, Satyanarayana Rachagani, Moorthy P. Ponnusamy, and Surinder K. Batra. 2015. “Pathobiological Implications of Mucin Glycans in Cancer: Sweet Poison and Novel Targets.” Biochimica et Biophysica Acta 1856 (2): 211–225. https://doi.org/10.1016/j.bbcan.2015.08.003.
   PubMed Web of Science ®Google Scholar
• Clevers, Hans. 2006. “Wnt/β-Catenin Signaling in Development and Disease.” Cell 127 (3): 469–480. https://doi.org/10.1016/j.cell.2006.10.018.
   PubMed Web of Science ®Google Scholar
• DeSantis, Carol E., Jiemin Ma, Mia M. Gaudet, Lisa A. Newman, Kimberly D. Miller, Ann Goding Sauer, Ahmedin Jemal, and Rebecca L. Siegel. 2019. “Breast Cancer Statistics, 2019.” CA: A Cancer Journal for Clinicians 69 (6): 438–451. https://doi.org/10.3322/caac.21583.
   PubMed Web of Science ®Google Scholar
• Ezeh, Uche I., Paul J. Turek, Renee A. Reijo, and Amander T. Clark. 2005. “Human Embryonic Stem Cell genes OCT4, NANOG, STELLAR, andGDF3 Are Expressed in Both Seminoma and Breast Carcinoma.” Cancer 104 (10): 2255–2265. https://doi.org/10.1002/cncr.21432.
   PubMed Web of Science ®Google Scholar
• Fong, Helen, Kristi A. Hohenstein, and Peter J. Donovan. 2008. “Regulation of Self-Renewal and Pluripotency by SOX2 in Human Embryonic Stem Cells.” Stem Cells 26 (8): 1931–1938. https://doi.org/10.1634/stemcells.2007-1002.
   PubMed Web of Science ®Google Scholar
• Gadwal, Ashita, Anupama Modi, Manoj Khokhar, Jeewan Ram Vishnoi, Ramkaran Choudhary, Poonam Elhence, Mithu Banerjee, and Purvi Purohit. 2022. “Critical Appraisal of Epigenetic Regulation of Galectins in Cancer.” International Journal of Clinical Oncology 27 (1): 35–44. https://doi.org/10.1007/s10147-021-02048-x.
   PubMed Web of Science ®Google Scholar
• Gasch, Claudia, Brendan Ffrench, John J. O'Leary, and Michael F. Gallagher. 2017. “Catching Moving Targets: Cancer Stem Cell Hierarchies, Therapy-Resistance & Considerations for Clinical Intervention.” Molecular Cancer 16 (1): 43. https://doi.org/10.1186/s12943-017-0601-3.
   PubMedGoogle Scholar
• Gen, Yasuyuki, Kohichiroh Yasui, Yoh Zen, Keika Zen, Osamu Dohi, Mio Endo, Kazuhiro Tsuji, et al. 2010. “SOX2 Identified as a Target Gene for the Amplification at 3q26 That Is Frequently Detected in Esophageal Squamous Cell Carcinoma.” Cancer Genetics and Cytogenetics 202 (2): 82–93. https://doi.org/10.1016/j.cancergencyto.2010.01.023.
   PubMedGoogle Scholar
• Ghahhari, Nastaran Mohammadi, and Sadegh Babashah. 2015. “Interplay between microRNAs and WNT/β-Catenin Signalling Pathway Regulates Epithelial–Mesenchymal Transition in Cancer.” European Journal of Cancer 51 (12): 1638–1649. https://doi.org/10.1016/j.ejca.2015.04.021.
   PubMed Web of Science ®Google Scholar
• Gomes, Joana, Nuno T. Marcos, Nora Berois, Eduardo Osinaga, Ana Magalhães, João Pinto-de-Sousa, Raquel Almeida, Fátima Gärtner, and Celso A. Reis. 2009. “Expression of UDP-N-Acetyl-D-Galactosamine: Polypeptide N-Acetylgalactosaminyltransferase-6 in Gastric Mucosa, Intestinal Metaplasia, and Gastric Carcinoma.” The Journal of Histochemistry and Cytochemistry 57 (1): 79–86. https://doi.org/10.1369/jhc.2008.952283.
   PubMed Web of Science ®Google Scholar
• Győrffy, Balázs. 2021. “Survival Analysis across the Entire Transcriptome Identifies Biomarkers with the Highest Prognostic Power in Breast Cancer.” Computational and Structural Biotechnology Journal 19: 4101–4109. https://doi.org/10.1016/j.csbj.2021.07.014.
   PubMed Web of Science ®Google Scholar
• Hatsell, Sarah, Tracey Rowlands, Minoti Hiremath, and Pamela Cowin. 2003. “β-Catenin and TCFs in Mammary Development and Cancer.” Journal of Mammary Gland Biology and Neoplasia 8 (2): 145–158. https://doi.org/10.1023/A:1025944723047.
   PubMed Web of Science ®Google Scholar
• Hromas, Robert, Matthew Hufford, Jill Sutton, Dawei Xu, Yunxing Li, and Li Lu. 1997. “PLAB, a Novel Placental Bone Morphogenetic Protein.” Biochimica et Biophysica Acta 1354 (1): 40–44. https://doi.org/10.1016/S0167-4781(97)00122-X.
   PubMedGoogle Scholar
• Huanna, Tian, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, et al. 2015. “GALNT14 Mediates Tumor Invasion and Migration in Breast Cancer Cell MCF-7: GALNT14 Mediates Tumor Invasion in MCF-7.” Molecular Carcinogenesis 54 (10): 1159–1171. https://doi.org/10.1002/mc.22186.
   PubMed Web of Science ®Google Scholar
• Jang, Gyu-Beom, Ji-Young Kim, Sung-Dae Cho, Ki-Soo Park, Ji-Youn Jung, Hwa-Yong Lee, In-Sun Hong, and Jeong-Seok Nam. 2015. “Blockade of Wnt/β-Catenin Signaling Suppresses Breast Cancer Metastasis by Inhibiting CSC-like Phenotype.” Scientific Reports 5 (1): 12465. https://doi.org/10.1038/srep12465.
   PubMedGoogle Scholar
• Johnen, Heiko, Tamara Kuffner, David A. Brown, Ben J. Wu, Roland Stocker, and Samuel N. Breit. 2012. “Increased Expression of the TGF-b Superfamily Cytokine MIC-1/GDF15 Protects ApoE−/− Mice from the Development of Atherosclerosis.” Cardiovascular Pathology 21 (6): 499–505. https://doi.org/10.1016/j.carpath.2012.02.003.
   PubMed Web of Science ®Google Scholar
• Joshi, Jayashree P., Nicole E. Brown, Samantha E. Griner, and Rita Nahta. 2011. “Growth Differentiation Factor 15 (GDF15)-Mediated HER2 Phosphorylation Reduces Trastuzumab Sensitivity of HER2-Overexpressing Breast Cancer Cells.” Biochemical Pharmacology 82 (9): 1090–1099. https://doi.org/10.1016/j.bcp.2011.07.082.
   PubMed Web of Science ®Google Scholar
• Kalli, Maria, Angeliki Minia, Vaia Pliaka, Christos Fotis, Leonidas G. Alexopoulos, and Triantafyllos Stylianopoulos. 2019. “Solid Stress-Induced Migration Is Mediated by GDF15 through Akt Pathway Activation in Pancreatic Cancer Cells.” Scientific Reports 9 (1): 978. https://doi.org/10.1038/s41598-018-37425-6.
   PubMedGoogle Scholar
• Khan, Zahid, Maha Arafah, Jilani P. Shaik, Alka Mahale, and Mohammad Alanazi. 2018. “High-Frequency Deregulated Expression of Wnt Signaling Pathway Members in Breast Carcinomas.” OncoTargets and Therapy 11 (January): 323–335. https://doi.org/10.2147/OTT.S154395.
   PubMedGoogle Scholar
• King, Taj D., Mark J. Suto, and Yonghe Li. 2012. “The Wnt/β-Catenin Signaling Pathway: A Potential Therapeutic Target in the Treatment of Triple Negative Breast Cancer.” Journal of Cellular Biochemistry 113 (1): 13–18. https://doi.org/10.1002/jcb.23350.
   PubMed Web of Science ®Google Scholar
• Kumar, S. M., S. Liu, H. Lu, H. Zhang, P. J. Zhang, P. A. Gimotty, M. Guerra, W. Guo, and X. Xu. 2012. “Acquired Cancer Stem Cell Phenotypes through Oct4-Mediated Dedifferentiation.” Oncogene 31 (47): 4898–4911. https://doi.org/10.1038/onc.2011.656.
   PubMed Web of Science ®Google Scholar
• Kwon, Ok-Seon, Ensel Oh, Jeong-Rak Park, Ji-Seon Lee, Gab-Yong Bae, Jae-Hyung Koo, Hyongbum Kim, et al. 2015. “GalNAc-T14 Promotes Metastasis through Wnt Dependent HOXB9 Expression in Lung Adenocarcinoma.” Oncotarget 6 (39): 41916–41928. https://doi.org/10.18632/oncotarget.6019.
   PubMedGoogle Scholar
• Lawton, Lee N., Maria de Fatima Bonaldo, Pierre C. Jelenc, Ling Qiu, Susan A. Baumes, Rudy A. Marcelino, Gracielle M. de Jesus, et al. 1997. “Identification of a Novel Member of the TGF-Beta Superfamily Highly Expressed in Human Placenta.” Gene 203 (1): 17–26. https://doi.org/10.1016/S0378-1119(97)00485-X.
   PubMed Web of Science ®Google Scholar
• Li, Shuguang, Shanshan Li, Ying Sun, and Li Li. 2014. “The Expression of β-Catenin in Different Subtypes of Breast Cancer and Its Clinical Significance.” Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 35 (8): 7693–7698. https://doi.org/10.1007/s13277-014-1975-0.
   PubMedGoogle Scholar
• Li, Xuefei, Yingxi Xu, Yanan Chen, Si Chen, Xianpei Jia, Tongchao Sun, Yanhua Liu, Xiru Li, Rong Xiang, and Na Li. 2013. “SOX2 Promotes Tumor Metastasis by Stimulating Epithelial-to-Mesenchymal Transition via Regulation of WNT/β-Catenin Signal Network.” Cancer Letters 336 (2): 379–389. https://doi.org/10.1016/j.canlet.2013.03.027.
   PubMed Web of Science ®Google Scholar
• Liesche, Friederike, Alexandra C. Kölbl, Matthias Ilmer, Stefan Hutter, Udo Jeschke, and Ulrich Andergassen. 2016. “Role of N-Acetylgalactosaminyltransferase 6 in Early Tumorigenesis and Formation of Metastasis.” Molecular Medicine Reports 13 (5): 4309–4314. https://doi.org/10.3892/mmr.2016.5044.
   PubMed Web of Science ®Google Scholar
• Lin, Jiaying, Suyoun Chung, Koji Ueda, Koichi Matsuda, Yusuke Nakamura, and Jae-Hyun Park. 2017. “GALNT6 Stabilizes GRP78 Protein by O-Glycosylation and Enhances Its Activity to Suppress Apoptosis Under Stress Condition.” Neoplasia 19 (1): 43–53. https://doi.org/10.1016/j.neo.2016.11.007.
   PubMed Web of Science ®Google Scholar
• Liu, Cai-gang, Ying Lu, Bin-bin Wang, Yan-jun Zhang, Rui-shan Zhang, Yang Lu, Bo Chen, Huimian Xu, Feng Jin, and Ping Lu. 2011. “Clinical Implications of Stem Cell Gene Oct-4 Expression in Breast Cancer.” Annals of Surgery 253 (6): 1165–1171. https://doi.org/10.1097/SLA.0b013e318214c54e.
   PubMed Web of Science ®Google Scholar
• Liu, Chang, Zhi Li, Lu Xu, Yu Shi, Xiaojie Zhang, Sha Shi, Kezuo Hou, et al. 2020. “GALNT6 Promotes Breast Cancer Metastasis by Increasing Mucin-Type O-Glycosylation of α2M.” Aging 12 (12): 11794–11811. https://doi.org/10.18632/aging.103349.
   PubMedGoogle Scholar
• Liu, Chengcheng, Laura J. Janke, Jun J. Yang, William E. Evans, John D. Schuetz, and Mary V. Relling. 2017. “Differential Effects of Thiopurine Methyltransferase (TPMT) and Multidrug Resistance-Associated Protein Gene 4 (MRP4) on Mercaptopurine Toxicity.” Cancer Chemotherapy and Pharmacology 80 (2): 287–293. https://doi.org/10.1007/s00280-017-3361-2.
   PubMed Web of Science ®Google Scholar
• Liu, Yan., Wei Ji, You Yin, Lan Fan, Jian Zhang, Huang Yun, Nianci Wang, et al. 2009. “The Effects of Splicing Variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA Expressions.” Clinica Chimica Acta; International Journal of Clinical Chemistry 403 (1–2): 142–144. https://doi.org/10.1016/j.cca.2009.02.006.
   PubMed Web of Science ®Google Scholar
• Malanchi, Ilaria, Albert Santamaria-Martínez, Evelyn Susanto, Hong Peng, Hans-Anton Lehr, Jean-Francois Delaloye, and Joerg Huelsken. 2012. “Interactions between Cancer Stem Cells and Their Niche Govern Metastatic Colonization.” Nature 481 (7379): 85–89. https://doi.org/10.1038/nature10694.
   Web of Science ®Google Scholar
• Mani, Sendurai A., Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y. Zhou, Mary Brooks, et al. 2008. “The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells.” Cell 133 (4): 704–715. https://doi.org/10.1016/j.cell.2008.03.027.
   PubMed Web of Science ®Google Scholar
• Mao, Yingge, Yuqi Zhang, Sairong Fan, Lvao Chen, Lili Tang, Xiaoming Chen, and Jianxin Lyu. 2019. “GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-Catenin/MUC1-C Signaling Pathway.” International Journal of Biological Sciences 15 (1): 169–182. https://doi.org/10.7150/ijbs.29048.
   PubMed Web of Science ®Google Scholar
• Modi, Anupama, Purvi Purohit, Ashita Gadwal, Dipayan Roy, Sujoy Fernandes, Jeewan Ram Vishnoi, Puneet Pareek, Poonam Elhence, Sanjeev Misra, and Praveen Sharma. 2021. “A Combined Analysis of Serum Growth Differentiation Factor-15 and Cancer Antigen 15-3 Enhances the Diagnostic Efficiency in Breast Cancer.” Ejifcc 32 (3): 363–376.
   PubMedGoogle Scholar
• Modi, Anupama, Purvi Purohit, Dipayan Roy, Jeewan Ram Vishnoi, Puneet Pareek, Poonam Elhence, Priyanka Singh, Shailja Sharma, Praveen Sharma, and Sanjeev Misra. 2022. “FOXM1 Mediates GDF-15 Dependent Stemness and Intrinsic Drug Resistance in Breast Cancer.” Molecular Biology Reports 49 (4): 2877–2888. https://doi.org/10.1007/s11033-021-07102-5.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy, Joyce A. 2002. “Pemetrexed: An Active New Agent for Breast Cancer.” Seminars in Oncology 29 (6S): 57–62. https://doi.org/10.1053/sonc.2002.37474.
   PubMedGoogle Scholar
• Openo, Kyle P., Mark M. Kadrofske, Ronald J. Patterson, and John L. Wang. 2000. “Galectin-3 Expression and Subcellular Localization in Senescent Human Fibroblasts.” Experimental Cell Research 255 (2): 278–290. https://doi.org/10.1006/excr.1999.4782.
   PubMed Web of Science ®Google Scholar
• Park, Jae-Hyun, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, and Toyomasa Katagiri. 2010. “Critical Roles of Mucin 1 Glycosylation by Transactivated Polypeptide N -Acetylgalactosaminyltransferase 6 in Mammary Carcinogenesis.” Cancer Research 70 (7): 2759–2769. https://doi.org/10.1158/0008-5472.CAN-09-3911.
   PubMed Web of Science ®Google Scholar
• Parodi, Armando J. 2000. “Protein Glucosylation and Its Role in Protein Folding.” Annual Review of Biochemistry 69 (1): 69–93. https://doi.org/10.1146/annurev.biochem.69.1.69.
   PubMedGoogle Scholar
• Pereira, Jonathas Xavier, Sofia Nascimento dos Santos, Thaís Canuto Pereira, Mariana Cabanel, Roger Chammas, Felipe Leite de Oliveira, Emerson Soares Bernardes, and Márcia Cury El-Cheikh. 2019. “Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer.” Journal of Oncology 2019 (December): 9827147. https://doi.org/10.1155/2019/9827147.
   PubMedGoogle Scholar
• Pesce, Maurizio, Xiangyuan Wang, Debra J. Wolgemuth, and Hans R. Schöler. 1998. “Differential Expression of the Oct-4 Transcription Factor during Mouse Germ Cell Differentiation.” Mechanisms of Development 71 (1–2): 89–98. https://doi.org/10.1016/S0925-4773(98)00002-1.
   PubMed Web of Science ®Google Scholar
• Piva, Marco, Giacomo Domenici, Oihana Iriondo, Miriam Rábano, Bruno M. Simões, Valentine Comaills, Inmaculada Barredo, et al. 2014. “SOX2 Promotes Tamoxifen Resistance in Breast Cancer Cells.” EMBO Molecular Medicine 6 (1): 66–79. https://doi.org/10.1002/emmm.201303411.
   PubMed Web of Science ®Google Scholar
• Prasad, Chandra P., Gayatri Rath, Sandeep Mathur, Dinesh Bhatnagar, Rajinder Parshad, and Ranju Ralhan. 2009. “Expression Analysis of E-Cadherin, Slug and GSK3β in Invasive Ductal Carcinoma of Breast.” BMC Cancer 9 (1): 325. https://doi.org/10.1186/1471-2407-9-325.
   PubMedGoogle Scholar
• Que, Jianwen, Xiaoyan Luo, Robert J. Schwartz, and Brigid L. M. Hogan. 2009. “Multiple Roles for SOX2 in the Developing and Adult Mouse Trachea.” Development 136 (11): 1899–1907. https://doi.org/10.1242/dev.034629.
   PubMed Web of Science ®Google Scholar
• Ravindran, Gokulan, Sharada S. Sawant, Angela Hague, Karl Kingsley, and Halagowder Devaraj. 2015. “Association of Differential B-Catenin Expression with Oct-4 and Nanog in Oral Squamous Cell Carcinoma and Their Correlation with Clinicopathological Factors and Prognosis.” Head & Neck 37 (7): 982–993. https://doi.org/10.1002/hed.23699.
   PubMed Web of Science ®Google Scholar
• Sasahara, Asako, Kana Tominaga, Tatsunori Nishimura, Masao Yano, Etsuko Kiyokawa, Miki Noguchi, Masakuni Noguchi, et al. 2017. “An Autocrine/Paracrine Circuit of Growth Differentiation Factor (GDF) 15 Has a Role for Maintenance of Breast Cancer Stem-like Cells.” Oncotarget 8 (15): 24869–24881. https://doi.org/10.18632/oncotarget.15276.
   PubMedGoogle Scholar
• Schepers, Goslik E., Rohan D. Teasdale, and Peter Koopman. 2002. “Twenty Pairs of SOX.” Developmental Cell 3 (2): 167–170. https://doi.org/10.1016/S1534-5807(02)00223-X.
   PubMed Web of Science ®Google Scholar
• Schjoldager, Katrine T.-B. G., and Henrik Clausen. 2012. “Site-Specific Protein O-Glycosylation Modulates Proprotein Processing—Deciphering Specific Functions of the Large Polypeptide GalNAc-Transferase Gene Family.” Biochimica et Biophysica Acta 1820 (12): 2079–2094. https://doi.org/10.1016/j.bbagen.2012.09.014.
   PubMed Web of Science ®Google Scholar
• Shekhar, Malathy P. V., Pratima Nangia-Makker, Larry Tait, Fred Miller, and Avraham Raz. 2004. “Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer Progression.” The American Journal of Pathology 165 (6): 1931–1941. https://doi.org/10.1016/S0002-9440(10)63245-2.
   PubMed Web of Science ®Google Scholar
• Shen, Tiansheng, Kui Zhang, Gene P. Siegal, and Shi Wei. 2016. “Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer.” American Journal of Clinical Pathology 146 (5): 603–610. https://doi.org/10.1093/ajcp/aqw183.
   PubMed Web of Science ®Google Scholar
• Sherman, Brad T., Ming Hao, Ju Qiu, Xiaoli Jiao, Michael W. Baseler, H. Clifford Lane, Tomozumi Imamichi, and Weizhong Chang. 2022. “DAVID: A Web Server for Functional Enrichment Analysis and Functional Annotation of Gene Lists (2021 Update).” Nucleic Acids Research 50 (W1): W216–W221. https://doi.org/10.1093/nar/gkac194.
   PubMed Web of Science ®Google Scholar
• Shimura, Tatsuo, Yukinori Takenaka, Souichi Tsutsumi, Victor Hogan, Akira Kikuchi, and Avraham Raz. 2004. “Galectin-3, a Novel Binding Partner of β-Catenin.” Cancer Research 64 (18): 6363–6367. https://doi.org/10.1158/0008-5472.CAN-04-1816.
   PubMed Web of Science ®Google Scholar
• Simone, Giuseppina, Natalia Malara, Valentina Trunzo, Maria Renne, Gerardo Perozziello, Enzo Di Fabrizio, and Andreas Manz. 2014. “Galectin-3 Coats the Membrane of Breast Cells and Makes a Signature of Tumours.” Molecular bioSystems 10 (2): 258–265. https://doi.org/10.1039/C3MB70359B.
   PubMedGoogle Scholar
• Suzuki, H., M. Toyota, H. Carraway, E. Gabrielson, T. Ohmura, T. Fujikane, N. Nishikawa, et al. 2008. “Frequent Epigenetic Inactivation of Wnt Antagonist Genes in Breast Cancer.” British Journal of Cancer 98 (6): 1147–1156. https://doi.org/10.1038/sj.bjc.6604259.
   PubMed Web of Science ®Google Scholar
• Szklarczyk, Damian, Annika L. Gable, David Lyon, Alexander Junge, Stefan Wyder, Jaime Huerta-Cepas, Milan Simonovic, et al. 2019. “STRING V11: Protein–Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets.” Nucleic Acids Research 47 (D1): D607–D613. https://doi.org/10.1093/nar/gky1131.
   PubMed Web of Science ®Google Scholar
• Takahashi, Kazutoshi, and Shinya Yamanaka. 2006. “Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors.” Cell 126 (4): 663–676. https://doi.org/10.1016/j.cell.2006.07.024.
   PubMed Web of Science ®Google Scholar
• Tarhan, Yunus Emre, Taigo Kato, Miran Jang, Yoshimi Haga, Koji Ueda, Yusuke Nakamura, and Jae-Hyun Park. 2016. “Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.” Neoplasia 18 (5): 265–272. https://doi.org/10.1016/j.neo.2016.03.005.
   PubMed Web of Science ®Google Scholar
• Vitiazeva, Varvara, Jayesh J. Kattla, Sarah A. Flowers, Sara K. Lindén, Pushpa Premaratne, Birgitta Weijdegård, Karin Sundfeldt, and Niclas G. Karlsson. 2015. “The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.” PLOS One 10 (6): e0130197. https://doi.org/10.1371/journal.pone.0130197.
   PubMed Web of Science ®Google Scholar
• Wan, Fang, Xin Chen, Li-Fan Dong, Yue-Hong Cheng, and Jing-Pei Long. 2014. “A Systemic Analysis on Pemetrexed in Treating Patients with Breast Cancer.” Asian Pacific Journal of Cancer Prevention 15 (11): 4567–4570. https://doi.org/10.7314/APJCP.2014.15.11.4567.
   PubMedGoogle Scholar
• Wang, Yumin, Xiaorui Wu, Zhao Ren, Yulin Li, Wailong Zou, Jichao Chen, and Hongquan Wang. 2023. “Overcoming Cancer Chemotherapy Resistance by the Induction of Ferroptosis.” Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 66 (January): 100916. https://doi.org/10.1016/j.drup.2022.100916.
   PubMedGoogle Scholar
• Wang, Ziyi, Hao Zhang, Jianxin Hou, Jianing Niu, Zhenhai Ma, Haidong Zhao, and Caigang Liu. 2015. “Clinical Implications of β-Catenin Protein Expression in Breast Cancer.” International Journal of Clinical and Experimental Pathology 8 (11): 14989–14994.
   PubMed Web of Science ®Google Scholar
• Wu, Chen, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, et al. 2010. “N-Acetylgalactosaminyltransferase-14 as a Potential Bio­marker for Breast Cancer by Immunohistochemistry.” BMC Cancer 10 (1): 123. https://doi.org/10.1186/1471-2407-10-123.
   PubMedGoogle Scholar
• Xu, Qiong, Hai-Xu Xu, Jin-Ping Li, Song Wang, Zheng Fu, Jing Jia, Li Wang, Zhi-Feng Zhu, Rong Lu, and Zhi Yao. 2017. “Growth Differentiation Factor 15 Induces Growth and Metastasis of Human Liver Cancer Stem-like Cells via AKT/GSK-3β/β-Catenin Signaling.” Oncotarget 8 (10): 16972–16987. https://doi.org/10.18632/oncotarget.15216.
   PubMedGoogle Scholar
• Yarema, Kevin J., and Carolyn R. Bertozzi. 2001. “Characterizing Glycosylation Pathways.” Genome Biology 2 (5): reviews0004.1. https://doi.org/10.1186/gb-2001-2-5-reviews0004.
   Web of Science ®Google Scholar
• Zachara, Natasha E., and Gerald W. Hart. 2006. “Cell Signaling, the Essential Role of O-GlcNAc!.” Biochimica et Biophysica Acta 1761 (5–6): 599–617. https://doi.org/10.1016/j.bbalip.2006.04.007.
   PubMed Web of Science ®Google Scholar
• Zhang, Hao, Minna Luo, Xi Liang, Dan Wang, Xin Gu, Chao Duan, Huizi Gu, et al. 2014. “Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.” PLOS One 9 (9): e103482. https://doi.org/10.1371/journal.pone.0103482.
   PubMed Web of Science ®Google Scholar